Furthermore, the study of the nuclear IL-33 action will be useful to evaluate the possible interactions with tumor-related transcription factors, and the modulation of nuclear IL-33 expression could represent a possible therapeutic approach. This evidence concerns the gene IL33 and neoplasm.